National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 28529-28530 [2014-11248]

Download as PDF Federal Register / Vol. 79, No. 95 / Friday, May 16, 2014 / Notices reorganization plans for the NIDA extramural program in establishment of a Division of Extramural Research based on initial discussions, public comment and feedback at the NIDA Advisory Council on Drug Abuse Meeting on May 7th. The proposal seeks to clearly delineate functions and streamline the services provided within the Office of the Director, as well as capitalize on emerging scientific opportunities, while reducing barriers to scientific and interdisciplinary collaboration. Members of the public wishing to attend must view the discussion via webex link https://nidaevents.webex.com/nida-events/onstage/ g.php?d=660244762&t=a and enter the audio conference information above from their telephone. Upon opening the link provided, please contact your IT support group for assistance in uploading any necessary drivers (e.g. MBR2 player) prior to the start of this event. Dated: May 8, 2014. Nora Volkow, Director, National Institute on Drug Abuse, National Institutes of Health. [FR Doc. 2014–11253 Filed 5–15–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health EMCDONALD on DSK67QTVN1PROD with NOTICES Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Advisory Committee to the Director, National Institutes of Health. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Mar<15>2010 20:00 May 15, 2014 Jkt 232001 Name of Committee: Advisory Committee to the Director, National Institutes of Health. Date: June 5–6, 2014. Open: June 05, 2014, 9:00 a.m. to 4:15 p.m. Agenda: NIH Director’s Report, NIH Updates, and other business of the committee. Place: National Institutes of Health, Building 1, Room 126, 1 Center Drive, Bethesda, MD 20892. Closed: June 05, 2014, 4:15 p.m. to 5:15 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 1, Room 126, 1 Center Drive, Bethesda, MD 20892. Open: June 06, 2014, 9:00 a.m. to 12:00 p.m. Agenda: ACD Working Group reports, NIH updates, and other business of the committee. Place: National Institutes of Health, Building 1, Room 126, 1 Center Drive, Bethesda, MD 20892. Contact Person: Gretchen Wood, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1, Room 103, Bethesda, MD 20892, 301–496–4272, woodgs@od.nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// acd.od.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: May 12, 2014. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2014–11251 Filed 5–15–14; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 28529 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group Kidney, Urologic and Hematologic Diseases D Subcommittee. Date: June 18–19, 2014. Open: June 18, 2014, 8:00 a.m. to 8:30 a.m. Agenda: To review policy and procedures. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Closed: June 18, 2014, 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Closed: June 19, 2014, 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Barbara A. Woynarowska, Ph.D., Scientific Review Administrator, Review Branch, DEA, NIDDK, National Institutes of Health, Room 754, 6707 Democracy Boulevard, Bethesda, MD 20892– 5452, (301) 402–7172, woynarowskab@ niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group Diabetes, Endocrinology and Metabolic Diseases B Subcommittee. Date: June 18–20, 2014. Open: June 18, 2014, 3:00 p.m. to 3:30 p.m. Agenda: To review policy and procedures. Place: The Palmer House Hilton, 17 East Monroe Street, Chicago, IL 60603. E:\FR\FM\16MYN1.SGM 16MYN1 28530 Federal Register / Vol. 79, No. 95 / Friday, May 16, 2014 / Notices EMCDONALD on DSK67QTVN1PROD with NOTICES Closed: June 18, 2014, 3:30 p.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: The Palmer House Hilton, 17 East Monroe Street, Chicago, IL 60603. Closed: June 19, 2014, 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Palmer House Hilton, 17 East Monroe Street, Chicago, IL 60603. Closed: June 20, 2014, 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: The Palmer House Hilton, 17 East Monroe Street, Chicago, IL 60603. Contact Person: John F. Connaughton, Ph.D., Chief, Chartered Committees Section, Review Branch, DEA, NIDDK, National Institutes of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892– 5452, (301) 594–7797, connaughtonj@ extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group Digestive Diseases and Nutrition C Subcommittee. Date: June 26–27, 2014. Open: June 26, 2014, 8:00 a.m. to 8:30 a.m. Agenda: To review policy and procedures. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Closed: June 26, 2014, 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Closed: June 27, 2014, 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Robert Wellner, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 706, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, rw175w@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: May 12, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–11248 Filed 5–15–14; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 20:00 May 15, 2014 Jkt 232001 DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2014–0352] Merchant Marine Personnel Advisory Committee Coast Guard, DHS. Notice of Federal Advisory Committee Teleconference Meeting. AGENCY: ACTION: The Merchant Marine Personnel Advisory Committee (MERPAC) will meet, via teleconference, to discuss Task Statement 80, concerning crew training requirements onboard vessels subject to the International Code of Safety for ships using gases or low flashpoint fuels (IGF Code). This meeting will be open to the public. DATES: The teleconference meeting will take place on June 10, 2014, from 1 p.m. until 3 p.m. EST. Please note that this meeting may adjourn early if all business is finished. Written comments for distribution to committee members and inclusion on the MERPAC Web site must be submitted on or before June 3, 2014. Members of the public wishing to attend must register with Mr. Davis Breyer, ADFO of MERPAC no later than June 3, 2014. Contact Mr. Breyer as indicated in the FOR FURTHER INFORMATION CONTACT section of this notice no later than June 3, 2014 to register as a speaker. ADDRESSES: To participate by phone, contact the Alternate Designated Federal Officer (ADFO) listed below in the FOR FURTHER INFORMATION CONTACT section to obtain teleconference information. Note the number of teleconference lines is limited and will be available on a firstcome, first-served basis. To join those participating in this teleconference from U.S. Coast Guard Headquarters, come to Room 6J07–02, 2703 Martin Luther King Jr Ave. SE., Washington, DC 20593– 7509. Due to security at the Coast Guard Headquarters building, members of the public wishing to attend must register with Mr. Davis Breyer, ADFO of MERPAC, at (202) 372–1445 or davis.j.breyer@uscg.mil. All visitors to Coast Guard Headquarters must provide identification in the form of a Government issued picture identification card for access to the facility. Please arrive at least 30 minutes before the planned start of the meeting in order to pass through security. For information on facilities or services for individuals with disabilities or to request special assistance, contact the Alternate Designated Federal Officer SUMMARY: PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 (ADFO) listed below in the FOR FURTHER section as soon as possible. To facilitate public participation, we are inviting public comment on the issues to be considered by the committee as listed in the ‘‘Agenda’’ section below. Written comments must be identified by Docket No. USCG– 2014–0352 submitted by one of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments (preferred method to avoid delays in processing). • Fax: 202–493–2251. • Mail: Docket Management Facility (M–30), U.S. Department of Transportation, West Building Ground Floor, Room W12–140, 1200 New Jersey Avenue SE., Washington, DC 20590– 0001. • Hand delivery: Same as mail address above, between 9 a.m. and 5 p.m., Monday through Friday, except Federal Holidays. The telephone number is 202–366–9329. Instructions: All submissions received must include the words ‘‘Department of Homeland Security’’ and the docket number for this action. Comments received will be posted without alteration at https://regulations.gov, including any personal information provided. You may review a Privacy Act notice regarding our public dockets in the January 17, 2008, issue of the Federal Register (73 FR 3316). Docket: For access to the docket to read documents or comments related to this notice, go to https:// www.regulations.gov, enter the docket number in the ‘‘Search’’ field and follow the instructions on the Web site. A public oral comment period will be held after the working group report. Speakers are requested to limit their comments to 3 minutes. Please note that the public oral comment period will end following the last call for comments. This notice may be viewed in our online docket, USCG–2014–0352, at https:// www.regulations.gov. INFORMATION CONTACT Mr. Davis Breyer, Alternate Designated Federal Officer (ADFO), telephone 202– 372–1445, or at davis.j.breyer@uscg.mil. If you have any questions on viewing or submitting material to the docket, call Cheryl Collins, Program Manager, Docket Operations, telephone 202–366– 9826 or 1–800–647–5527. SUPPLEMENTARY INFORMATION: Notice of this meeting is given under the Federal Advisory Committee Act (FACA), Title 5, United States Code, Appendix (Pub. L. 92–463). FOR FURTHER INFORMATION CONTACT: E:\FR\FM\16MYN1.SGM 16MYN1

Agencies

[Federal Register Volume 79, Number 95 (Friday, May 16, 2014)]
[Notices]
[Pages 28529-28530]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11248]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Initial Review Group Kidney, Urologic and 
Hematologic Diseases D Subcommittee.
    Date: June 18-19, 2014.
    Open: June 18, 2014, 8:00 a.m. to 8:30 a.m.
    Agenda: To review policy and procedures.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Closed: June 18, 2014, 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Closed: June 19, 2014, 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Barbara A. Woynarowska, Ph.D., Scientific Review 
Administrator, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 754, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 
(301) 402-7172, woynarowskab@niddk.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Initial Review Group Diabetes, Endocrinology and 
Metabolic Diseases B Subcommittee.
    Date: June 18-20, 2014.
    Open: June 18, 2014, 3:00 p.m. to 3:30 p.m.
    Agenda: To review policy and procedures.
    Place: The Palmer House Hilton, 17 East Monroe Street, Chicago, 
IL 60603.

[[Page 28530]]

    Closed: June 18, 2014, 3:30 p.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Palmer House Hilton, 17 East Monroe Street, Chicago, 
IL 60603.
    Closed: June 19, 2014, 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Palmer House Hilton, 17 East Monroe Street, Chicago, 
IL 60603.
    Closed: June 20, 2014, 8:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Palmer House Hilton, 17 East Monroe Street, Chicago, 
IL 60603.
    Contact Person: John F. Connaughton, Ph.D., Chief, Chartered 
Committees Section, Review Branch, DEA, NIDDK, National Institutes 
of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-
5452, (301) 594-7797, connaughtonj@extra.niddk.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Initial Review Group Digestive Diseases and 
Nutrition C Subcommittee.
    Date: June 26-27, 2014.
    Open: June 26, 2014, 8:00 a.m. to 8:30 a.m.
    Agenda: To review policy and procedures.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Closed: June 26, 2014, 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Closed: June 27, 2014, 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Robert Wellner, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 706, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 
rw175w@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: May 12, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-11248 Filed 5-15-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.